Back

Learner’s Digest International (TM)

  • Antibodies, Bispecific
  • Immunotherapy
  • Multiple Myeloma

Novel Targets for Immunotherapy in Multiple Myeloma

The goal of this program is to improve the management of multiple myeloma. After hearing and assimilating this program, the clinician will be better able to:Compare the use of bispecific antibodies with other immunotherapeutic approaches in multiple myeloma.Analyze patient-specific factors and disease characteristics that influence the selection of appropriate targeted therapies in multiple myeloma.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Jul 7, 2028 2 years left